EDGAR Filing Documents for 0001047469-03-006549

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001047469-03-006549

Filing Date

2003-02-24

Accepted

2003-02-24 14:27:28

Documents

Period of Report

2002-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	20-F	a2103086z20-f.htm	20-F	2443357
3	EX-1.1	a2103086zex-1_1.htm	EX-1.1	59452
4	EX-1.2	a2103086zex-1_2.htm	EX-1.2	72545
5	EX-4.2	a2103086zex-4_2.htm	EX-4.2	4396
6	EX-4.3	a2103086zex-4_3.htm	EX-4.3	19875
7	EX-10.1	a2103086zex-10_1.htm	EX-10.1	2406
8	EX-10.2	a2103086zex-10_2.htm	EX-10.2	4404
9	G706780.JPG	g706780.jpg	GRAPHIC	8945
10	G903347.JPG	g903347.jpg	GRAPHIC	8371
	Complete submission text file	0001047469-03-006549.txt		2626043

Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056

Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056

NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 03577317
SIC: 2834 Pharmaceutical Preparations